PGRMC1 and breast carcinoma: High PGRMC1 expression was observed in 35 of 49 TNBC patients (71.14%), which is slightly higher than that we have been reported in breast cancer of all subtypes (69.60%, 48/69) (Ruan et al., 2017) (Figure 2).